Literature DB >> 18755839

Activation of cap-independent translation by variant eukaryotic initiation factor 4G in vivo.

Constanze Kaiser1, Elena Y Dobrikova, Shelton S Bradrick, Mayya Shveygert, James T Herbert, Matthias Gromeier.   

Abstract

Protein synthesis is tightly controlled by assembly of an intricate ribonucleoprotein complex at the m(7)GTP-cap on eukaryotic mRNAs. Ensuing linear scanning of the 5' untranslated region (UTR) is believed to transfer the preinitiation complex to the initiation codon. Eukaryotic mRNAs are characterized by significant 5' UTR heterogeneity, raising the possibility of differential control of translation initiation rate at individual mRNAs. Curiously, many mRNAs with unconventional, highly structured 5' UTRs encode proteins with central biological roles in growth control, metabolism, or stress response. The 5' UTRs of such mRNAs may influence protein synthesis rate in multiple ways, but most significantly they have been implicated in mediating alternative means of translation initiation. Cap-independent initiation bypasses strict control over the formation of initiation intermediates at the m(7)GTP cap. However, the molecular mechanisms that favor alternative means of ribosome recruitment are not understood. Here we provide evidence that eukaryotic initiation factor (eIF) 4G controls cap-independent translation initiation at the c-myc and vascular endothelial growth factor (VEGF) 5' UTRs in vivo. Cap-independent translation was investigated in tetracycline-inducible cell lines expressing either full-length eIF4G or a C-terminal fragment (Ct) lacking interaction with eIF4E and poly(A) binding protein. Expression of Ct, but not intact eIF4G, potently stimulated cap-independent initiation at the c-myc/VEGF 5' UTRs. In vitro RNA-binding assays suggest that stimulation of cap-independent translation initiation by Ct is due to direct association with the c-myc/VEGF 5' UTR, enabling 43S preinitiation complex recruitment. Our work demonstrates that variant translation initiation factors enable unconventional translation initiation at mRNA subsets with distinct structural features.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755839      PMCID: PMC2553731          DOI: 10.1261/rna.1171808

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  63 in total

Review 1.  Transcriptional regulation and transformation by Myc proteins.

Authors:  Sovana Adhikary; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

2.  Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia.

Authors:  I Stein; A Itin; P Einat; R Skaliter; Z Grossman; E Keshet
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  C-Myc 5' untranslated region contains an internal ribosome entry segment.

Authors:  M Stoneley; F E Paulin; J P Le Quesne; S A Chappell; A E Willis
Journal:  Oncogene       Date:  1998-01-22       Impact factor: 9.867

4.  Eukaryotic translation initiation factor 4GI and p97 promote cellular internal ribosome entry sequence-driven translation.

Authors:  Patrick Hundsdoerfer; Christian Thoma; Matthias W Hentze
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-07       Impact factor: 11.205

5.  Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection.

Authors:  A Gradi; Y V Svitkin; H Imataka; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

6.  Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site.

Authors:  C Nanbru; I Lafon; S Audigier; M C Gensac; S Vagner; G Huez; A C Prats
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

7.  Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites.

Authors:  G Johannes; P Sarnow
Journal:  RNA       Date:  1998-12       Impact factor: 4.942

8.  Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines.

Authors:  M J Clemens; M Bushell; S J Morley
Journal:  Oncogene       Date:  1998-12-03       Impact factor: 9.867

9.  The predominant elF4G-specific cleavage activity in poliovirus-infected HeLa cells is distinct from 2A protease.

Authors:  M L Bovee; W E Marissen; M Zamora; R E Lloyd
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.616

10.  Translational activation of uncapped mRNAs by the central part of human eIF4G is 5' end-dependent.

Authors:  E De Gregorio; T Preiss; M W Hentze
Journal:  RNA       Date:  1998-07       Impact factor: 4.942

View more
  32 in total

Review 1.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

2.  MAPK signal-integrating kinase controls cap-independent translation and cell type-specific cytotoxicity of an oncolytic poliovirus.

Authors:  Christian Goetz; Richard G Everson; Linda C Zhang; Matthias Gromeier
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

Review 3.  Role of translation initiation factor 4G in lifespan regulation and age-related health.

Authors:  Amber Howard; Aric N Rogers
Journal:  Ageing Res Rev       Date:  2014-01-03       Impact factor: 10.895

Review 4.  Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.

Authors:  Christian Goetz; Matthias Gromeier
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-17       Impact factor: 7.638

5.  The Nup153-Nup50 protein interface and its role in nuclear import.

Authors:  Masaki Makise; Douglas R Mackay; Suzanne Elgort; Sunita S Shankaran; Stephen A Adam; Katharine S Ullman
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157

6.  Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.

Authors:  Oshrat Attar-Schneider; Victoria Zismanov; Liat Drucker; Maya Gottfried
Journal:  Tumour Biol       Date:  2015-10-30

7.  Oncolytic poliovirus against malignant glioma.

Authors:  Christian Goetz; Elena Dobrikova; Mayya Shveygert; Mikhail Dobrikov; Matthias Gromeier
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

8.  Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.

Authors:  Arash Minai-Tehrani; Seung-Hee Chang; Jung-Taek Kwon; Soon-Kyung Hwang; Ji-Eun Kim; Ji-Young Shin; Kyeong-Nam Yu; Sung-Jin Park; Hu-Lin Jiang; Ji-Hye Kim; Seong-Ho Hong; Bitna Kang; Duyeoul Kim; Chan-Hee Chae; Kee-Ho Lee; George R Beck; Myung-Haing Cho
Journal:  Cell Oncol (Dordr)       Date:  2012-10-16       Impact factor: 6.730

9.  Poly(A)-binding protein modulates mRNA susceptibility to cap-dependent miRNA-mediated repression.

Authors:  Robert W Walters; Shelton S Bradrick; Matthias Gromeier
Journal:  RNA       Date:  2009-11-24       Impact factor: 4.942

10.  Identification of gemin5 as a novel 7-methylguanosine cap-binding protein.

Authors:  Shelton S Bradrick; Matthias Gromeier
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.